Related Experiment Videos

Cyclin D1 and esophageal adenocarcinoma risk: how good does a marker have to be?

Journal of the National Cancer Institute

|August 17, 2000

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients.

British journal of cancer·2012

11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours.

British journal of cancer·2006

Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.

Annals of epidemiology·2001

Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Controlled clinical trials·2001

Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.

Controlled clinical trials·2001

See all related articles